| Gerald N. Herman |
Gerald N. Herman is currently the Co-Managing Director at Luxendo GmbH. He is also the Director at Bruker Cellular Analysis, Inc. and the Chief Financial Officer & Executive Vice President at Bruker Corp. Mr. Herman previously worked as the Director at Bruker UK Ltd. and as the Vice President-Finance at The First Years, Inc. He also held positions as the Vice President & Controller at Presstek LLC from 2005 to 2008 and as the Vice President-Clinical Operations at PAREXEL International Corp. from 2008 to 2016. Prior to that, he was a Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr. Herman has a graduate degree from Bentley University and an MBA from The University of Chicago. |
| Frank H. Laukien |
Frank H. Laukien is currently the Chairman, President & Chief Executive Officer at Bruker Corp. He is also a Director at Bruker Energy & Supercon Technologies, Inc., Bruker Daltonics, Inc., Bruker BioSpin Corp., and the Analytical Life Science & Diagnostics Association. Additionally, he holds the position of Professor at Harvard University. Previously, Laukien served as the Co-Chief Executive Officer at Bruker Biospin Group in 2010, the Executive Chairman at Bruker AXS, Inc. from 1997 to 2003, and as a Trustee at The Rivers School Corp. from 2006 to 2013. Laukien obtained a doctorate degree from Harvard University and an undergraduate degree from the Massachusetts Institute of Technology. |
| Falko Busse |
Falko Busse currently works at Mestrelab Research SL, as Chairman from 2019, Optimal Industrial Automation Ltd., as Director from 2022, Bruker Corp., as President-Bruker BioSpin Group from 2018, Bruker BioSpin Holding GmbH, as President from 2018, Bruker BioSpin Corp., as President, and Bruker Biospin Group, as President from 2018. Dr. Busse received his undergraduate degree and doctorate degree from the University of Bonn. |
| Cynthia M. Friend |
Cynthia M. Friend is currently an Independent Director at Bruker Corp. since 2016. She is also the Director of the Energy Frontier Research Centre at Harvard University since 2014. Dr. Friend is the President of The Kavli Foundation since 2021 and a Member of the National Academy of Sciences since 2019. In her former positions, she was the Associate Director at Slac National Accelerator Laboratory from 2011 to 2012, the Director of The Rowland Institute for Science from 2013 to 2019, and the Associate Director of the Materials Research Science & Engineering Center from 2001 to 2011. Friend holds a doctorate degree from the University of California, Berkeley. |
| Bonnie H. Anderson |
Bonnie H. Anderson founded Veracyte, Inc. in 2006, where she worked as Chairman & Chief Executive Officer from 2017 to 2021. Ms. Anderson also currently works at PiNK Diagnostics LLC, as Chairman & Chief Executive Officer, Bruker Corp., as Independent Director from 2020, Keck Graduate Institute of Applied Life Sciences, as Director, DNA Script SAS, as Independent Director from 2021, and The Coalition for 21st Century Medicine, as President. Ms. Anderson also formerly worked at Beckman Coulter, Inc., as Director & Vice President from 2000 to 2006, Biotechnology Innovation Organization, as Director from 2015 to 2020, and Castle Biosciences, Inc., as Independent Director from 2015 to 2020. Ms. Anderson received her undergraduate degree in 2012 from Indiana University of Pennsylvania. |
| Hermann Fritz Requardt |
Hermann Fritz Requardt is currently the Chairman at Siemens Medical Solutions USA, Inc., Vice Chairman at Fraunhofer-Gesellschaft eV, Chairman-Supervisory Board at Sivantos GmbH, Chairman at Siemens Japan Holding KK, Independent Director at Bruker Corp., Director at Bruker Daltonics, Inc., Non-Executive Director at Sphere Medical Ltd., and Director at Siemens Healthcare Diagnostics, Inc. In the past, Dr. Requardt served as the Chief Executive Officer-Healthcare Sector at Siemens AG, Chairman-Supervisory Board at VDO Automotive AG, Chairman-Supervisory Board at SuperSonic Imagine SA, Chairman at Siemens Healthcare KK, Non-Executive Director at Sphere Medical Holding Ltd., Director-Supervisory Board at BSH Hausgeräte GmbH, Member-Supervisory Board at Software AG, Member-Supervisory Board at OSRAM GmbH, and Vice President at Deutsche Akademie der Technikwissenschaften eV. Dr. Requardt obtained a graduate degree from the University of Oxford, an undergraduate degree from Technische Universität Darmstadt, and undergraduate and doctorate degrees from Johann Wolfgang Goethe-Universität Frankfurt am Main. |
| Adelene Q. Perkins |
Adelene Q. Perkins founded Scidera Genomics LLC, where she worked as Chief Executive Officer. Ms. Perkins also currently works at Project HOPE-The-People-To-People HealthFoundation, Inc., as Vice Chairman from 2013, Bruker Corp., as Independent Director from 2017, Biotechnology Innovation Organization, as Director from 2012, The General Hospital Corp., as Director from 2017, Bruker Daltonics, Inc., as Director, Massachusetts Biotechnology Council, as Director from 2014, and Villanova University College of Engineering, as Director. Ms. Perkins also formerly worked at Infinity Pharmaceuticals, Inc., as Chairman & Chief Financial Officer in 2023, Massachusetts Life Sciences Center, as Treasurer & Director from 2014 to 2016, Padlock Therapeutics, Inc., as Director, Genetics Institute LLC, as Vice President-Emerging Business from 1992 to 1999, TransForm Pharmaceuticals, Inc., as VP-Business & Corporate Development from 2000 to 2008, and Infinity Discovery, Inc., as Executive Vice President in 2006. Ms. Perkins received her undergraduate degree from Villanova University and Masters Business Admin degree from Harvard Business School. |
| Richard A. Packer |
Richard A. Packer is currently serving as the Chairman at ZOLL Medical Corp. since 2016. He is also an Independent Director at Bruker Corp. since 2007, a Director at ZOLL Lifecor Corp., Bolder Surgical LLC, the University of Massachusetts, Bruker Daltonics, Inc., The Medical Device Manufacturers Association, Massachusetts Medical Device Development Center, Zoll Foundation, and Senior Managing Executive Officer at Asahi Kasei Corp. In his former roles, Mr. Packer served as an Independent Director at Teleflex, Inc., a Director at Angiotech Pharmaceuticals, Inc., Surgical Specialties Corp., and the Massachusetts Medical Device Industry Council from 2011 to 2013. He was also a Manager at KPMG LLP and PRTM Management Consultants LLC. Prior to that, he held the position of Vice President at Whistler Corp. from 1987 to 1992. Mr. Packer completed his undergraduate and graduate studies at Rensselaer Polytechnic Institute. He also holds an MBA from Harvard Business School. |
| Robert J. Rosenthal |
Robert J. Rosenthal is currently the Chairman at Galvanic Applied Sciences, Inc., Chairman & Chief Innovation Officer at Taconic Biosciences, Inc., Chairman at Taconic Biosciences A, Chairman at Trace Bioanalytics LLC, Chairman at Care Everywhere LLC, Director at Matritech, Inc., Independent Director at Bruker Corp., Director at Cambrius, Inc., Director at The Echo Group, Inc., Director at Bruker Daltonics, Inc., Independent Director at Invivo Therapeutics Holdings Corp., and Director at Pathogenica, Inc. Previously, Dr. Rosenthal held positions as President & Chief Executive Officer at Alseres Pharmaceuticals, Inc., President, Chief Executive Officer & Director at TekCel, Inc., President, Chief Executive Officer & Director at Magellan Diagnostics, Inc., Chairman & Chief Executive Officer at IMI Intelligent Medical Implants AG, President & Chief Executive Officer at Magellan Discovery Technologies LLC, President & Chief Executive Officer at Magellan Biosciences, Inc., and Chairman at Safeguard Scientifics, Inc. He also served as Chairman at Sensor Innovations, Inc. and Director at PrimeraDx, Inc., MZT Holdings, Inc., and Nicolet Instrument Corp. Additionally, he was President-Instrument Division & Senior VP at Perkin Elmer Corp.Dr. Rosenthal's education includes an MBA from Stanford University, a doctorate from Emory University, an undergraduate degree from the University of Maryland, and a graduate degree from The State University of New York. |
| John A. Ornell |
John A. Ornell is an Independent Director at Bruker Corp. and a Vice President & Director at NuGenesis Technologies Corp. and a Director at Bruker Daltonics, Inc. He was previously a Director at Pediatrix Medical Group, Inc., a Vice President-Operations at EMD Millipore Corp., and the Chief Financial Officer & VP-Administration at Waters Corp. He holds an MBA from Southern New Hampshire University and an undergraduate degree from the University of New Hampshire. |
